J Guintivano1, P F Sullivan1, A M Stuebe2, T Penders3, J Thorp2, D R Rubinow1, S Meltzer-Brody1. 1. Department of Psychiatry,University of North Carolina,Chapel Hill, NC,USA. 2. Department of Obstetrics and Gynecology,University of North Carolina,NC,USA. 3. Department of Psychiatry and Behavioral Medicine,East Carolina University,NC,USA.
Abstract
BACKGROUND: Race, psychiatric history, and adverse life events have all been independently associated with postpartum depression (PPD). However, the role these play together in Black and Latina women remains inadequately studied. Therefore, we performed a case-control study of PPD, including comprehensive assessments of symptoms and biomarkers, while examining the effects of genetic ancestry. METHODS: We recruited our sample (549 cases, 968 controls) at 6 weeks postpartum from obstetrical clinics in North Carolina. PPD status was determined using the MINI-plus. Psychiatric history was extracted from medical records. Participants were administered self-report instruments to assess depression (Edinburgh Postnatal Depression Scale) and adverse life events. Levels of estradiol, progesterone, brain-derived neurotrophic factor, oxytocin, and allopregnanalone were assayed. Principal components from genotype data were used to estimate genetic ancestry and logistic regression was used to identify predictors of PPD. RESULTS: This population was racially diverse (68% Black, 13% Latina, 18% European). Genetic ancestry was not a predictor of PPD. Case status was predicted by a history of major depression (p = 4.01E-14), lifetime anxiety disorder diagnosis (p = 1.25E-34), and adverse life events (p = 6.06E-06). There were no significant differences between groups in any hormones or neurosteroids. CONCLUSIONS: Psychiatric history and multiple exposures to adverse life events were significant predictors of PPD in a population of minority and low-income women. Genetic ancestry and hormone levels were not predictive of case status. Increased genetic vulnerability in conjunction with risk factors may predict the onset of PPD, whereas genetic ancestry does not appear predictive.
BACKGROUND: Race, psychiatric history, and adverse life events have all been independently associated with postpartum depression (PPD). However, the role these play together in Black and Latina women remains inadequately studied. Therefore, we performed a case-control study of PPD, including comprehensive assessments of symptoms and biomarkers, while examining the effects of genetic ancestry. METHODS: We recruited our sample (549 cases, 968 controls) at 6 weeks postpartum from obstetrical clinics in North Carolina. PPD status was determined using the MINI-plus. Psychiatric history was extracted from medical records. Participants were administered self-report instruments to assess depression (Edinburgh Postnatal Depression Scale) and adverse life events. Levels of estradiol, progesterone, brain-derived neurotrophic factor, oxytocin, and allopregnanalone were assayed. Principal components from genotype data were used to estimate genetic ancestry and logistic regression was used to identify predictors of PPD. RESULTS: This population was racially diverse (68% Black, 13% Latina, 18% European). Genetic ancestry was not a predictor of PPD. Case status was predicted by a history of major depression (p = 4.01E-14), lifetime anxiety disorder diagnosis (p = 1.25E-34), and adverse life events (p = 6.06E-06). There were no significant differences between groups in any hormones or neurosteroids. CONCLUSIONS:Psychiatric history and multiple exposures to adverse life events were significant predictors of PPD in a population of minority and low-income women. Genetic ancestry and hormone levels were not predictive of case status. Increased genetic vulnerability in conjunction with risk factors may predict the onset of PPD, whereas genetic ancestry does not appear predictive.
Entities:
Keywords:
Adverse life events; genetic ancestry; postpartum depression; psychiatric history.
Authors: Rita Suri; Zachary N Stowe; Lee S Cohen; D Jeffrey Newport; Vivien K Burt; Ana R Aquino-Elias; Bettina T Knight; Jim Mintz; Lori L Altshuler Journal: J Clin Psychiatry Date: 2017 Sep/Oct Impact factor: 4.384
Authors: Michele L Okun; Jim Luther; Aric A Prather; James M Perel; Stephen Wisniewski; Katherine L Wisner Journal: J Affect Disord Date: 2010-08-12 Impact factor: 4.839
Authors: A Di Florio; K Putnam; M Altemus; G Apter; V Bergink; J Bilszta; R Brock; A Buist; K M Deligiannidis; E Devouche; C N Epperson; C Guille; D Kim; P Lichtenstein; P K E Magnusson; P Martinez; T Munk-Olsen; J Newport; J Payne; B W Penninx; M O'Hara; E Robertson-Blackmore; S J Roza; K M Sharkey; S Stuart; H Tiemeier; A Viktorin; P J Schmidt; P F Sullivan; Z N Stowe; K L Wisner; I Jones; D R Rubinow; S Meltzer-Brody Journal: Psychol Med Date: 2016-11-21 Impact factor: 7.723
Authors: V Uzunova; Y Sheline; J M Davis; A Rasmusson; D P Uzunov; E Costa; A Guidotti Journal: Proc Natl Acad Sci U S A Date: 1998-03-17 Impact factor: 11.205
Authors: D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar Journal: J Clin Psychiatry Date: 1998 Impact factor: 4.384
Authors: Hudson P Santos; Arjun Bhattacharya; Elizabeth M Martin; Kezia Addo; Matt Psioda; Lisa Smeester; Robert M Joseph; Stephen R Hooper; Jean A Frazier; Karl C Kuban; T Michael O'Shea; Rebecca C Fry Journal: Epigenetics Date: 2019-05-21 Impact factor: 4.528
Authors: Taylor A Thul; Elizabeth J Corwin; Nicole S Carlson; Patricia A Brennan; Larry J Young Journal: Psychoneuroendocrinology Date: 2020-07-06 Impact factor: 4.905
Authors: Sharon Dekel; Tsachi Ein-Dor; Zohar Berman; Ida S Barsoumian; Sonika Agarwal; Roger K Pitman Journal: Arch Womens Ment Health Date: 2019-04-30 Impact factor: 3.633
Authors: Hudson P Santos; Benjamin C Nephew; Arjun Bhattacharya; Xianming Tan; Laura Smith; Reema Abdulrahman S Alyamani; Elizabeth M Martin; Krista Perreira; Rebecca C Fry; Christopher Murgatroyd Journal: Psychoneuroendocrinology Date: 2018-08-16 Impact factor: 4.905